CAROL SWICKER: Open Payments
NPI 1619683372 · BIDDEFORD, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 12 payments from 6 companies in 2025. Trend: 2023 $1,088 · 2024 $1,950 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $379 |
| GENZYME CORPORATION | 3 | $192 |
| Amgen Inc. | 2 | $51 |
| Philips North America LLC | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Verona Pharma, Inc. | 1 | $19 |
Products named: FASENRA, DUPIXENT, TEZSPIRE, Vest Therapy Und, NUCALA, Ohtuvayre.
Industry payments across ME — which companies pay providers there.
